非缺血性扩张型心肌病患者心脏MRI致心律失常基质评估对心脏性猝死的风险分层
本研究纳入四个中心的1105例非缺血性扩张型心肌病患者,在开发队列(n=837)和外部验证队列(n=268)中评估晚期钆增强(LGE)与T1 mapping对心脏性猝死的预测价值。结果显示LGE≥7.2%左室质量、ECV≥31.8%和native T1 z评分≥2.1与SCD相关事件独立相关;LGE≥7.2%者年事件率4.65%,而LVEF>35%、LGE<7.2%且ECV<31.8%者年事件率仅0.2%。
要点
- LGE≥7.2%左室质量者SCD相关事件年发生率为4.65%,无论ECV、native T1值及LGE分布/模式如何。
- ECV≥31.8%且无LGE者SCD事件风险高于ECV<31.8%且LGE<7.2%或壁内/局灶LGE者。
- LVEF>35%、LGE<7.2%且ECV<31.8%者SCD风险低,年事件率0.2%。
核心结论
- 在非缺血性扩张型心肌病中,LGE≥7.2%左室质量可强烈预测SCD风险,与分布和模式无关;ECV可显著增强风险分层,尤其在LGE阴性或局灶和/或壁内LGE患者中。
研究设计与样本
- 研究纳入四个中心1105例接受心脏MRI的非缺血性扩张型心肌病患者,数据在开发队列(n=837,单中心)和外部验证队列(n=268,多中心)中分析;主要终点包括SCD、适当植入式心律转复除颤器放电和复苏性心脏骤停。
关键影像表现/征象
- LGE≥7.2%左室质量者SCD相关事件年发生率为4.65%,无论ECV、native T1值及LGE分布和/或模式如何。
- ECV≥31.8%且无LGE者SCD事件风险高于ECV<31.8%且LGE<7.2%或壁内和/或局灶LGE者。
- LVEF>35%、LGE<7.2%且ECV<31.8%者SCD风险低,年事件率为0.2%。
诊断标准与关键数值
- LGE≥7.2%左室质量与SCD相关事件独立相关(HR 4.75,95%CI 2.91–7.74,P<.001)。
- ECV≥31.8%与SCD相关事件独立相关(HR 2.91,95%CI 1.63–5.22,P=.001)。
- native T1 z评分≥2.1与SCD相关事件独立相关(HR 1.69,95%CI 1.04–2.74,P=.04)。
- LVEF>35%、LGE<7.2%且ECV<31.8%者SCD年事件率为0.2%。
- LGE≥7.2%者SCD相关事件年发生率为4.65%。
临床应用与阅片要点
- 基于已验证的MRI预测因子开发了SCD风险评估的风险算法和临床工作流程。
- LGE≥7.2%左室质量可强烈预测SCD风险,与LGE分布和/或模式无关。
- ECV可显著增强风险分层,尤其在LGE阴性或局灶和/或壁内LGE患者中。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background MRI-derived arrhythmogenic substrate, including late gadolinium enhancement (LGE) and extracellular volume fraction (ECV), is indicative of sudden cardiac death (SCD) risk in nonischemic dilated cardiomyopathy (DCM). The relative prognostic value of LGE and ECV remains unclear. Purpose To evaluate the performance of LGE and T1 mapping in predicting SCD in patients with DCM and to explore clinical implementation. Materials and Methods This study enrolled 1105 patients with DCM who underwent cardiac MRI at four centers. The data were analyzed in a development cohort (n = 837, single center) and an external validation cohort (n = 268, multicenter). The primary end point comprised SCD, appropriate implantable cardioverter-defibrillator shock, and resuscitated cardiac arrest. The secondary end point comprised heart failure-related death, heart transplant, and left ventricle (LV) assist device implantation. Risk algorithms and a clinical workflow for SCD risk assessment were developed based on validated MRI predictors. Results In the development cohort, 78 patients reached the primary end point and 120 reached the secondary end point over a median follow-up of 58.3 months. In the adjusted analysis, LGE of at least 7.2% of the LV mass (hazard ratio [HR], 4.75 [95% CI: 2.91, 7.74]; P < .001), an ECV of at least 31.8% (HR, 2.91 [95% CI: 1.63, 5.22]; P = .001), and a native T1 z score of at least 2.1 (HR, 1.69 [95% CI: 1.04, 2.74]; P = .04) were associated with SCD-related events. Patients with an ECV of at least 31.8% and no LGE were at a higher risk of SCD events compared with those with an ECV less than 31.8% and presence of LGE of less than 7.2% or midwall and/or focal LGE. Patients with an LV ejection fraction greater than 35%, LGE less than 7.2%, and an ECV less than 31.8% exhibited a low risk of SCD, with an annual event rate of 0.2%. Patients with LGE of at least 7.2% exhibited a high risk of SCD-related events (annual event rate, 4.65%) irrespective of ECV and native T1 value and LGE distribution and/or pattern. Conclusion In nonischemic DCM, LGE of at least 7.2% was strongly predictive of SCD risk irrespective of distribution and pattern. ECV significantly enhanced risk stratification, particularly in patients with negative or focal and/or midwall LGE. © RSNA, 2025 Supplemental material is available for this article. See also the editorial by Sakuma in this issue.
引用
- Zhou D, Zhang H, Yang W, et al. Risk Stratification of Sudden Cardiac Death in Nonischemic Dilated Cardiomyopathy: Arrhythmogenic Substrate Assessment in Cardiac MRI. Radiology. 2025. PMID: 40923889. doi:10.1148/radiol.243427
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。